S Zhaveri Pharmakem Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 31-07-2024
- Paid Up Capital ₹ 1.97 M
as on 31-07-2024
- Company Age 19 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 281.25 M
as on 31-07-2024
- Revenue 5.96%
(FY 2023)
- Profit 10.00%
(FY 2023)
- Ebitda 41.45%
(FY 2023)
- Net Worth -15.74%
(FY 2023)
- Total Assets -14.76%
(FY 2023)
About S Zhaveri Pharmakem
The Company is engaged in the Chemicals And Resources Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 1.97 M.
The company has closed loans amounting to ₹28.13 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Uma Javeri, Mohammed Aldoori, Laith Aldoori, and One other member serve as directors at the Company.
- CIN/LLPIN
U51397MH2005PTC153790
- Company No.
153790
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jun 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Kalyan, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does S Zhaveri Pharmakem Private Limited offer?
S Zhaveri Pharmakem Private Limited offers a wide range of products and services, including Pharmaceutical Excipients, Croscarmellose Sodium, Weather & Meteorological Equipments, Weather Instruments, Autoclaves, Sterilizers & Incubators, UV Sterilizer and Lamps, Pharma Ingredients & Raw Materials, API Intermediate.
Who are the key members and board of directors at S Zhaveri Pharmakem?
Board Members(4)
Financial Performance and Corporate Structure Insights of S Zhaveri Pharmakem.
S Zhaveri Pharmakem Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.96% increase. The company also saw a in profitability, with a in profit. The company's net worth observed a substantial decline by a decrease of 15.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of S Zhaveri Pharmakem?
In 2023, S Zhaveri Pharmakem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Archimedis Healthcare Private Limited
Active
10 years 3 months Mohammed Al-Doori, Laith Aldoori and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 Mar 2021 | ₹5.00 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 20 Mar 2014 | ₹10.00 Cr | Satisfied |
Standard Chartered Bank Creation Date: 22 Mar 2010 | ₹4.50 Cr | Satisfied |
How Many Employees Work at S Zhaveri Pharmakem?
S Zhaveri Pharmakem has a workforce of 165 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Feb 25, 2014, S Zhaveri Pharmakem has raised a total of ₹ 13.95 Cr, with the most recent deal valued at ₹ 0.22 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
